Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 305.50
Ask: 306.50
Change: 3.50 (1.16%)
Spread: 1.00 (0.327%)
Open: 300.00
High: 306.50
Low: 300.00
Prev. Close: 302.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

6 Dec 2022 07:00

RNS Number : 6717I
Morgan Advanced Materials PLC
06 December 2022
 

Press Release

Morgan Advanced Materials plc

6 December 2022

 

Capital Markets Event

"Delivering resilient, scalable growth"

Morgan Advanced Materials plc will hold a Capital Markets Event this afternoon at the Science Museum in London.

The event will include a series of presentations by our senior leadership team, which will focus on our opportunities for profitable growth as a global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications. These include specific initiatives to drive sustainable growth through the industrial cycle.

We also set out the following through the cycle financial objectives:

- Accelerating Organic Revenue Growth. Extending our position in faster growing markets, supporting 3-6% p.a.

- Attractive Margins. 12.5% - 15% adjusted operating profit margin

- Delivering EPS Growth.  Achieving enhanced growth in adjusted Earnings per Share, ahead of organic revenue growth, driven by a combination of organic growth, inorganic activity and shareholder returns

- Leverage Range. 1.0x to 2.0x adjusted EBITDA

- Sustaining ROIC. 17 - 20% ROIC

In addition, we set out the following capital allocation policies:

- Focussing Organic Investment.  Investment to enhance growth and returns, including an additional £60m of capital in our Semiconductor manufacturing capacity over the next few years

- Enhancing Regular Returns via a Progressive Dividend Policy. Grow the regular dividend through the cycle with an adjusted earnings cover of c.2.5x

- Inorganic Activity. Complementary, disciplined M&A focused on accelerating revenue growth opportunities in faster growing markets

- Additional Returns. Additional returns of surplus capital to shareholders as appropriate.

The presentation for the event will be made available at www.morganadvancedmaterials.com at 14:00 UK time today. A recording of the presentation will be made available following the event.

Accelerated Pension Contribution

We have agreed with the Trustees of our UK Defined Benefit Pension Schemes a contribution of £67m that will create further balance sheet flexibility whilst substantially reducing future cash contributions. Further detail is provided in a separate RNS released today.

RCF Renewal

We have secured a new five-year Revolving Credit Facility of £230m that replaces our existing RCF that was due to mature in 2023.

FY22 Guidance

Our outlook and guidance for full year 2022 provided in our Trading Update of 4 November 2022 remain unchanged.

 

For further enquiries:

Pete Raby, CEO

Morgan Advanced Materials plc

01753 837000

Richard Armitage, CFO

Nina Coad

Brunswick

0207 404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVSWRUBUURAA
Date   Source Headline
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.